Inflammation and wasting in chronic kidney disease: Partners in crime

Slides:

Advertisements

Similar presentations

Stephen P. McDonald, Graeme R. Russ Kidney International

Advertisements

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

LDL cholesterol in CKD—to treat or not to treat?

Beta blockers in the management of chronic kidney disease

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Volume 70, Pages S138-S145 (November 2006)

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

High prevalence of chronic kidney disease in Thailand

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,

Reassessment of the care of the patient with chronic kidney disease

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

John P. Middleton, Patrick H. Pun Kidney International

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

J-Shaped Mortality Relationship for Uric Acid in CKD

Volume 70, Pages S21-S25 (December 2006)

The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age B.O. Eriksen, O.C. Ingebretsen Kidney International

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 71, Issue 2, Pages (January 2007)

Volume 72, Issue 9, Pages (November 2007)

French peritoneal dialysis registry (RDPLF): Outline and main results

Anemia as a risk factor for chronic kidney disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

A new era in phosphate binder therapy: What are the options?

Volume 70, Issue 11, Pages (December 2006)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

The epidemiology of chronic kidney disease

Benefits of preserving residual renal function in peritoneal dialysis

H. Wong, K. Mylrea, J. Feber, A. Drukker, G. Filler

Edmund G. Lowrie Kidney International

Volume 73, Pages S5-S17 (April 2008)

LDL cholesterol in CKD—to treat or not to treat?

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments R. Mishler, J.J. Sands, N.J. Ofsthun,

Acute myocardial infarction in patients with end-stage renal disease

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Blood pressure targets in hemodialysis patients

Volume 73, Issue 12, Pages (June 2008)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Microbiology and outcomes of peritonitis in North America

Methods for guideline development

Cardiovascular disease in pediatric chronic dialysis patients

The global challenge of chronic kidney disease

Lynda Anne Szczech, Ira L. Lazar Kidney International

Rajnish Mehrotra, Joel D. Kopple, Marsha Wolfson Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival.

Volume 73, Pages S72-S75 (April 2008)

Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Peter Stenvinkel, Peter Barany, Olof Heimbürger, Roberto Pecoits-Filho,

Arjang Djamali, Christina Kendziorski, Peter C. Brazy, Bryan N. Becker

E.A. Friedman, A.L. Friedman, P. Eggers Kidney International

Stephen P. McDonald, Graeme R. Russ Kidney International

Organ transplantation goes to the movies

Low triiodothyronine and survival in end-stage renal disease

Volume 70, Pages S84-S90 (November 2006)

Volume 72, Issue 2, Pages (July 2007)

Volume 70, Issue 7, Pages (October 2006)

Volume 70, Issue 7, Pages (October 2006)

Charles A. Herzog Kidney International

Volume 53, Issue 5, Pages (May 1998)

Fetuin-A is not associated with mortality in chronic kidney disease

Volume 70, Issue 5, Pages (September 2006)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Presentation transcript:

Inflammation and wasting in chronic kidney disease: Partners in crime C.M. Avesani, J.J. Carrero, J. Axelsson, A.R. Qureshi, B. Lindholm, P. Stenvinkel Kidney International Volume 70, Pages S8-S13 (December 2006) DOI: 10.1038/sj.ki.5001969 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Factors contributing to the occurrence of wasting in CKD. Kidney International 2006 70, S8-S13DOI: (10.1038/sj.ki.5001969) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Patients survival curve showing CDV mortality adjusted for age, gender, and diabetes in 310 CKD stage 5 patients divided according to the presence of wasting (subjective global assessment – SGA≥2) and inflammation (CRP≥10mg/l) at start of the dialysis treatment. Kidney International 2006 70, S8-S13DOI: (10.1038/sj.ki.5001969) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Potential pathways linking chronic inflammation to the development of wasting in CKD. Kidney International 2006 70, S8-S13DOI: (10.1038/sj.ki.5001969) Copyright © 2006 International Society of Nephrology Terms and Conditions